Cardiovascular
Final SPRINT study confirms benefits of aggressive BP management
June 2nd, 2021 Final results from the landmark SPRINT study confirm that aggressive blood pressure (BP) management, targeting a systolic blood pressure (SBP) below 120 mm Hg, significantly reduces the risk for heart disease, stroke, and death from these diseases,...
Experts urge action to reduce global burden of cardiovascular disease in women
May 26th, 2021 Urgent action is needed to improve care and prevention, fill knowledge gaps and increase awareness about cardiovascular disease in women, according to a report from the Lancet Commission. The first-ever global report on women and cardiovascular...
Baby Aspirin on par with full-dose for cardiovascular disease
May 19th, 2021 A large landmark study found that low-dose and regular-strength aspirin is equally safe and effective for preventing additional heart problems in people who already have heart disease, writes MedicalBrief. The ADAPTABLE trial was unusual in that...Omega-3 supplementation linked with atrial fibrillation risk — Meta-analysis
Omega-3 supplements are associated with an increased likelihood of developing atrial fibrillation in people with high blood lipids, a meta-analysis of randomised control trials published in the European Heart Journal found. "Currently, fish oil...
Lowering BP significantly reduces CV risk even at normal levels
May 5th, 2021 Even in those with normal or only mildly elevated blood pressure (BP), anti-hypertensive medication lowering of BP protects against future cardiovascular (CV) events, found a large meta-analysis in The Lancet. A 5 mm Hg reduction of systolic blood...'Striking' association of cardiovascular risk factors with late-life cognitive decline
An increase in risk factors for cardiovascular disease (CVD) during young adulthood is associated with cognitive decline in late life, a US data analysis shows. Investigators found a "novel, striking" association between high body mass index (BMI),...CVD the leading cause of death in patients with type 2 diabetes
Cardiovascular disease (CVD) was the leading cause of death among the over 16,000 patients with type 2 diabetes (T2DM) who were enrolled in the SAVOR-TIMI 53 trial. Two-thirds (66.3%) of all 798 deaths after a median 2.1 years of follow-up were...
Cancer survivors face elevated risk of cardiovascular disease over 10 years
March 24th, 2021 A study has found that about 35% of Americans with a cancer history had an elevated risk of atherosclerotic cardiovascular disease (ASCVD) in the next decade, compared with about 23% of those who didn't have cancer. Based on a risk calculator...Stroke risk higher than expected among COVID-19 patients
Research found patients hospitalized with COVID-19 had a higher risk of stroke, compared with patients who had similar infectious conditions such as influenza and sepsis in prior studies. Those who had an ischemic stroke were more likely to be...
Statins found to have no effect on muscle pain in placebo trial
March 3rd, 2021 A study has found no overall effect of statins on the frequency or severity of muscle symptoms compared with placebo in people who had previously reported severe symptoms when taking statins, found a London School of Hygiene and Tropical Medicine...Sex differences in 'normal' blood pressure and associated CVD risk
Women have a lower "normal" blood pressure range compared to men and that this is linked to risk for each specific cardiovascular disease (CVD) type, including heart attack, heart failure, and stroke, found a large study from the Smidt Heart...
Meta-analysis: No cardiovascular benefits to dietary supplements except vitamin B
February 3rd, 2021 No cardiovascular or mortality effects were seen with multivitamins, vitamin D, calcium, or vitamin C in a meta-analysis incorporating 156 randomised controlled trials and meta-analyses, according to a group led by Dr David Jenkins, of the...
Polypill plus aspirin reduces incidence of cardiovascular events by 31% — TIPS-3
January 27th, 2021 Researchers have found that combined treatment with a polypill plus aspirin led to a 31% lower incidence of cardiovascular events than did placebo among participants without cardiovascular disease (CVD) who were at intermediate cardiovascular risk,...
No limit to benefits of exercise in reducing risk of CVD — UK Biobank cohort study
January 20th, 2021 There is no upper threshold to the benefits of exercise in reducing the risk of cardiovascular disease (CVD), found the largest ever cohort study of its kind, conducted over five-years and led by the University of Oxford. Cardiovascular disease...
Inter-arm difference in BP robustly linked to greater early death risk
January 6th, 2021 Robust evidence from a large meta-analysis published in Hypertension confirms that a difference in blood pressure readings between arms is linked to greater risk of heart attack, stroke and death. The study provides a new upper limit of 'normal' for...